Litcius/Paper detail

Contraception and reproductive planning during the COVID-19 pandemic

Edson Santos Ferreira‐Filho, Nilson Roberto de Melo, Isabel Cristina Espósito Sorpreso, Luís Bahamondes, Ricardo Santos Simões, José Maria Soares, Edmund Chada Baracat

2020Expert Review of Clinical Pharmacology111 citationsDOI

Abstract

INTRODUCTION: The coronavirus disease (COVID-19) is a global health emergency. Major disruption to healthcare services during the current COVID-19 pandemic will last even after its peak. Sexual and reproductive health (SRH), specially contraception, needs to be understood as an essential service. AREAS COVERED: This paper is a narrative review. Data from PubMed/MEDLINE, Scopus, and websites of scientific societies were screened during the months of April and May 2020. It addresses the main aspects related to contraception during the COVID-19 pandemic, with special emphasis on family planning services, extended use of long-acting reversible contraceptive (LARC) methods, drug interactions, and thromboembolism risk. We also specified some issues focused on the Brazilian reality. EXPERT OPINION: Ensuring proper contraception use in the COVID-19 time is very important. We encourage women, healthcare providers, policymakers, and the society to consider SRH services as priority.

Topics & Concepts

PandemicMedicineEmergency contraceptionCoronavirus disease 2019 (COVID-19)Reproductive healthFamily planningHealth careMEDLINEScopusFamily medicinePopulationDiseaseEnvironmental healthEconomic growthInfectious disease (medical specialty)Political sciencePathologyLawResearch methodologyEconomicsCOVID-19 Impact on ReproductionReproductive Health and ContraceptionMale Reproductive Health Studies